Early detection of dementia through retinal imaging and trustworthy AI
Date published
Free to read from
Supervisor/s
Journal Title
Journal ISSN
Volume Title
Publisher
Department
Course name
Type
ISSN
Format
Citation
Abstract
Alzheimer's disease (AD) is a global healthcare challenge lacking a simple and affordable detection method. We propose a novel deep learning framework, Eye-AD, to detect Early-onset Alzheimer's Disease (EOAD) and Mild Cognitive Impairment (MCI) using OCTA images of retinal microvasculature and choriocapillaris. Eye-AD employs a multilevel graph representation to analyze intra- and inter-instance relationships in retinal layers. Using 5751 OCTA images from 1671 participants in a multi-center study, our model demonstrated superior performance in EOAD (internal data: AUC = 0.9355, external data: AUC = 0.9007) and MCI detection (internal data: AUC = 0.8630, external data: AUC = 0.8037). Furthermore, we explored the associations between retinal structural biomarkers in OCTA images and EOAD/MCI, and the results align well with the conclusions drawn from our deep learning interpretability analysis. Our findings provide further evidence that retinal OCTA imaging, coupled with artificial intelligence, will serve as a rapid, noninvasive, and affordable dementia detection.
Description
Software Description
Software Language
Github
Keywords
DOI
Rights
Funder/s
This work was supported in part by the National Science Foundation Program of China (62422122, 62272444, 62371442, 62302488), in part by the Youth Innovation Promotion Association CAS (2021298), in part by the Zhejiang Provincial Natural Science Foundation of China (LR22F020008, LQ23F010007, LR24F010002, LZ23F010002), in part by Key research and development program of Zhejiang Province (2024C03101, 2024C03204) and Key Project of Ningbo Public Welfare Science and Technology (2023S012). AFF acknowledges the support of the Royal Academy of Engineering Chair INSILEX (CiET1819\9), the UKRI Frontier Research Guarantee INSILICO (EP\Y030494\1). The research of AFF was carried out at the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) (NIHR203308).